Jade Biosciences
JBIO
Jade Biosciences (JBIO) earnings history
Most recent quarter
- Fiscal period
- Q2 2025
- Period end
- Jun 30, 2025
- EPS actual
- −$0.86
- EPS estimate
- −$0.43
- EPS surprise
- −98.48%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Aug 13, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2025 | Aug 13, 2025 | −$0.43 | −$0.86 | −98.48% | $0.00 | SEC |
| Q1 2025 | Apr 25, 2025 | −$6.03 | −$12.10 | −100.83% | $0.00 | SEC |
| Q4 2024 | Mar 27, 2025 | −$6.57 | −$6.65 | −1.17% | $0.00 | SEC |
| Q3 2024 | Nov 12, 2024 | −$16.36 | −$19.60 | −19.79% | $0.00 | SEC |
| Q2 2024 | Aug 12, 2024 | −$28.78 | −$30.10 | −4.58% | $0.00 | SEC |
| Q1 2024 | May 13, 2024 | −$26.76 | −$29.05 | −8.56% | $0.00 | SEC |
| Q4 2023 | Mar 25, 2024 | −$23.76 | −$25.90 | −9.00% | $0.00 | SEC |
| Q3 2023 | Nov 13, 2023 | −$24.24 | −$24.85 | −2.50% | $0.00 | SEC |
| Q2 2023 | Aug 14, 2023 | −$24.36 | −$26.60 | −9.20% | $0.00 | SEC |
| Q1 2023 | May 15, 2023 | −$21.00 | −$23.45 | −11.68% | $0.00 | SEC |
| Q4 2022 | Mar 29, 2023 | −$21.09 | −$21.35 | −1.22% | $0.00 | SEC |
| Q3 2022 | Nov 14, 2022 | −$17.44 | −$19.60 | −12.37% | $0.00 | SEC |
| Q2 2022 | Aug 15, 2022 | −$15.58 | −$17.15 | −10.11% | $0.00 | — |
| Q1 2022 | May 16, 2022 | −$9.74 | −$15.75 | −61.68% | $0.00 | — |
| Q4 2021 | Mar 30, 2022 | −$11.00 | −$11.90 | −8.20% | $0.00 | — |
| Q3 2021 | Nov 15, 2021 | −$9.10 | −$9.10 | +0.00% | $0.00 | — |
| Q2 2021 | Aug 16, 2021 | −$5.48 | −$833.00 | −15091.58% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did Jade Biosciences (JBIO) last report earnings?
Jade Biosciences last reported on Aug 13, 2025, covering fiscal Q2 2025.
Did JBIO beat earnings estimates?
No. Jade Biosciences reported EPS of −$0.86 for Q2 2025 against a −$0.43 estimate — a 98.48% miss.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.